Total Visits

Views
A pooled analysis of two randomized, double-blind placebo-controlled Phase III trials (STARTVerso1&2) of faldaprevir plus pegylated interferon alfa-2a and ribavirin in treatment-naive patients with chronic hepatitis C genotype-1 infection45

Select a period of time:

Views

Views
February 20252
March 20254
April 20252
May 20250
June 20250
July 202519
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil7
Singapore4
United Kingdom2
Chile1
Germany1
Spain1
Tunisia1
Turkey1
Venezuela1
 

Top cities views

Views
Augusta1
Barquisimeto1
Batley1
Brasília1
Council Bluffs1
Dallas1
Deer Park1
El Fahs1
Istanbul1
Jaguarão1